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ABSTRACT
Objective: The objective of this study was to assess the effect of the methanolic extract of Bauhinia variegata (L.) stem bark in albino rats.
Results: Oral BVMtE administration to high cholesterol diet (HCD)-fed rats significantly normalized the serum total cholesterol, low-density 
lipoprotein and very low-density lipoprotein cholesterol, triglycerides (TGs), phospholipid, aspartate and alanine transaminase, and alkaline and acid 
phosphatase. Reduced glutathione, superoxide dismutase, as well as atherogenic index of BVMtE-treated HCD rats showed significant normalcy as 
compared to HCD-fed rats. The histoarchitecture of heart and aorta of BVMtE-treated HCD-fed rats depicted marked normalcy as compared to HCD 
rats. Phytochemical analysis showed that plant is rich in active constituents, i.e., flavonoids, steroids, terpenoids, β-sitosterol, kaempferol-3-glucoside, 
and tannins.
Conclusions: B. variegata has proved lipid lowering as well as antioxidant activity in high cholesterol diet-fed animals.
Keywords: Oxidative stress, Low-density lipoprotein, Very low-density lipoproteins, Cardiovascular diseases.
INTRODUCTION
Many attempts have been made to explore the remedial option for 
hypercholesterolemic condition. Bauhinia variegata (Family – Fabaceae) 
is prescribed as antidiabetic [1,2], antibacterial [3], antioxidant [4], free 
radical scavenging [5,6], anti-inflammatory [7], anticarcinogenic [8], 
hepatoprotective [9], and antiulcer [10] agent. Although attempts were 
made to evaluate the hypolipidemic activity of B. variegata in rats [11,12], 
yet scientific validation is insufficient to prove its antihypercholesterolemic 
and antioxidant activity. Therefore, this study was undertaken to evaluate 
the antihypercholesterolemic and antioxidant potential of B. variegata in 
rats as well as screening of its active phytoconstituents.
METHODS
Preparation of extract and screening of phytoconstituents
B. variegata stem bark was freshly collected from the University 
of Rajasthan and authenticated by deposition of the specimen in 
Herbarium, Department of Botany, University of Rajasthan, Jaipur, India. 
Stem bark was shade dried and powdered for methanol extraction 
at 37°C ± 3°C. The filtrate was vacuum dried (yield 6.12% W/W) 
and treated with ethyl acetate for removal of fat portion. Lupeol was 
isolated with benzene and ethyl acetate elution in 3:1 ratio. The solvent 
was removed under reduced pressure and solid product so obtained 
was crystallized as colorless powder (m. p. 220°C).
Phytoconstituent screening of B. variegata revealed flavonoids, fixed oils, 
triterpenes saponins, tannins, glycosides, and polyphenols. Flavonoids 
such as apigenin, rutin, quercetin, apigenin 7-O-glucoside, quercitroside, 
rutoside, myricetin glycoside, β-isosterol, lupeol, kaempferol-3-
glucoside, and fibers were isolated from B. variegata [13,14].
Animal model
Adult Wistar rats (Rattus norvegicus) of either sex weighing 
(150–250 g) were used in the experiment. They were housed in 
clean and hygienic polypropylene cages and were maintained under 
standard conditions: temperature (25°C ± 2°C), 12 h light and dark 
cycles, humidity (55%±4%), and water were provided ad libitum. 
The experiment protocols were consented by the Institutional Animal 
Ethics Committee and conducted according to the guidelines of the 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA), New Delhi, India, registration no.1678/Go/
Re/S/12/CPCSEA dated June 16, 2017.
Acute toxicity studies
The acute toxicity of B. variegata extract was evaluated using the method 
of Lorke [15]. Rats were administered different doses of B. variegata 
extract, ranging from 1000 to 3000 mg⁄kg b. wt. for 21 days and were 
examined for mortality. The LD50 value of BS was found to be 2200 
mg⁄kg (data not shown). Two doses, i.e., 100 and 300 mg⁄kg b. wt./day 
were used in subsequent experiments.
The five experimental groups (n = 6 in each) used in the present 
study were as follows:
• Group I: Vehicle-treated control group kept on a normal diet
• Group II: Hypercholesterolemic (HCD) group
• Group III: BVME-treated (100 mg/g b. wt./day) HCD group
• Group IV: BVME-treated (200 mg/g b. wt./day) HCD group
• Group V: Atorvastatin-treated (40 µg/g b. wt./day) HCD group.
After animals were sacrificed, blood was collected by cardiac 
puncture and allowed to stand for 30 min. Later, centrifugation was 
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carried out at 2500 rpm for 20 min for serum separation for total 
cholesterol, triglycerides (TGs), HDL, LDL, VLDL, atherogenic index, and 
phospholipids (PL) estimation.
The superoxide dismutase (SOD), reduced glutathione (GSH), and lipid 
peroxidation (LPO) were conducted in liver, heart, and aorta.
RESULTS
The present study was conducted to explore the effect of the methanolic 
extract of B. variegata (L.) stem bark on high cholesterol-fed rats and 
screen the phytoconstituents present in the plant by high-performance 
liquid chromatography (HPLC) analysis. The plant material was 
collected and extracted in methanol and further subjected to HPLC 
analysis. The result obtained was a flavonoid compound quercetin at a 
wavelength of 365 nm that was compared with the standard at a peak 
of 365 nm. The results obtained by HPLC analysis have been shown in 
Fig. 1a and b.
BVME of dose level of 200 mg/kg b. wt and results of a dose level of 
100 mg/kg b. wt. were found to be nonsignificant and increment in the 
levels of HDL (p<0.05) in treated Group 4 and were nonsignificant in 
Group 3.
DISCUSSION
Due to side effects of synthetic drugs, herbal medicines have been main 
source of primary health care in all over the world. The medicinal plants 
play a major role in hypolipidemic activity [16]. Hence, this study was 
conducted to assess the hypolipidemic activity of B. variegata (L.) and 
to screen its active principles. The results of phytochemical analysis 
of the methanolic extract of BVME showed the presence of quercetin 
a flavonoid by HPLC analysis. It is reported that flavonoids are found 
to inhibit HMG-CoA reductase activity [17] and quercetin, a flavonoid 
has been proven to improve dyslipidemia, decrease oxidative stress 
through stimulation of lipolysis activity, and upregulate the adipocytes 
genes expression which increases the lipids beta-oxidation [18,19]. It 
may be concluded that the cholesterol-lowering effect of B. variegata 
(L.) bark extract may be due to inhibition of HMG-CoA reductase 
activity.
Table 1: Effect of Bauhinia variegata (L.) was extracted with methanol on total cholesterol, triglycerides, phospholipids, high-density 
lipoprotein, low-density lipoprotein, and very low-density lipoprotein levels in hyperlipidemic rats
Groups TC (mg/dL) TG (mg/dL) Phospholipids (mg/dL) HDL (mg/dL) LDL (mg/dL) VLDL (mg/dL)
I 114.35±4.28b 144.76±2.55b 110.05±4.03c 46.19±2.22b 44.39±2.05b 28.95±0.51b
II 136.61±3.50 159.72±3.82 131.91±3.12 35.25±1.89 54.90±2.28 31.94±0.76
III 121.46±2.39a 144.09±2.71b 116.47±2.53b 43.56±2.62a 46.45±1.65a 29.50±0.32a
IV 113.32±5.57b 142.54±3.74b 114.82±3.38b 47.35±2.41b 44.33±1.49b 28.51±0.75b
V 104.56±4.32c 137.15±2.24c 107.15±2.52c 51.34±1.12c 40.73±1.29c 27.43±0.45c
The data are expressed as mean±SEM; n=6 in each group. Control group (I); HCD group (II); HCD+BVME 100 mg/kg body weight (III); HCD+BVME 200 mg/kg 
body weight (IV); and HCD+atorvastatin 40 mg/kg body weight (V). Statistical significance testing for the comparisons was made by ANOVA, followed by post hoc 
test. ap<0.05, bp<0.01, cp<0.001, and nsp>0.05 compared with HCD group. HCD: High cholesterol diet, BVME: Bauhinia variegata (L.) was extracted with methanol, 
HDL: High-density lipoprotein, LDL: Low-density lipoprotein, VLDL: Very LDL, SEM: Standard error of mean, TC: Total cholesterol, TG: Triglyceride
Fig. 1: (a) High-performance liquid chromatography chromatogram of standard for the comparison of test sample of the methanolic bark 




All the observed data were expressed as mean ± standard error mean. 
The  data  were  analyzed  by  GraphPad  Prism  version  7.0. 
Statistical  significance  testing  for  the  comparisons  was  made  by 
one-way  ANOVA,  followed  by  post  hoc  test.  ap<0.05,  bp<0.01, 
cp<0.001, and nsp>0.05 compared with HCD group.
The oxidative stress parameters were analyzed in liver, heart, and aorta. 
Table 4 shows the results of the levels of SOD (Fig. 4), GSH (Fig. 5), and
 LPO (Fig. 6) in the tissues of liver, heart, and aorta. The levels of 
SOD and GSH (p<0.05) were significantly high in treated and standard 
group (Groups 4 and 5), whereas it was observed lower levels in case 
of HCD group and Group 3. The level of LPO (p<0.05) was measured
 by the TBARS method and it was found that there was an increment in 
the HCD group and Group 3, and there was a significant decrement in 
Groups 4 and 5.
The hepatic toxicity tests were performed in the serum. The levels 
of aspartate transaminase (AST) and alanine transferase (ALT)
 were increased in Group 2 and there was a decreased level
 of same in Groups 4 and 5. Similarly, the level of alkaline 
phosphatase (ALP) was also observed and there was increased level
 in Groups 2 and 3, decrement in Groups 4 and 5. Table 5 and Fig. 7 
depict the results.
Table 1 and Fig. 2 display the results of total cholesterol, TGs, and PL and 
Table 2 and Fig. 3 show the results of HDL, LDL, and VLDL. Furthermore, 
atherogenic index was calculated with the percentage protection of 
BVME. Table 3  shows the calculation of atherogenic index. It has been 
found that the rats fed on hypercholesterolemic diet (HCD) for 60 days 
resulted with increased levels of total cholesterol (TC), TGs, LDL, VLDL, 
and PL (p<0.05) in serum and simultaneous decrease in the level of HDL 
(p<0.05) in serum. Comparative to the rats fed on HCD and treated with 
doses of BVME, the results obtained were significantly different. There 
was a noteworthy change in the lipid profile which was comparable to 
the standard group. There was a consequential reduction in the levels 
of TC, TG, LDL, VLDL, and PL (p<0.05) in serum of treated group with 
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In this study, the Wistar rats were fed with hypercholesterolemic diet 
to induce the condition of hyperlipidemia. There were significant 
changes in the experimental groups. The lipid profile decreased in 
the BVME-treated groups whereas increased in the high cholesterol-
fed group. Shinde et al., 2013, also observed similar results with 
improvement in the lipid profile by administering Psidium guajava 
(L.) leaf extract to hyperlipidemic rats [20]. These results influenced 
the lipid metabolism and reverted to the changes significantly and 
it also suggests that cholesterol-lowering activity is associated with 
a decrease of its LDL fraction which can be a result from the rapid 
catabolism of LDL-C through its hepatic receptors for final elimination 
in the form of bile acids. It was also found that the administration 
of BVME in the animals that were fed with HCD increased the level 
of HDL which is considered to be good cholesterol as compared to 
the HCD group which lowered the levels of HDL. HDL facilitates the 
translocation of cholesterol from the peripheral tissue such as arterial 
walls to liver for catabolism. Hence, it is widely accepted that reduction 
HDL is a risk factor for developing cardiovascular diseases. It is also 
considered that increase in HDL may slow down the atherosclerotic 
process. Increased levels of HDL may be due to the increase in the 
activity of lecithin cholesterol acyltransferase, which plays a key role 
in incorporating the free cholesterol into HDL and transferring back 
to VLDLs or intermediate density lipoproteins, which are taken back 
by the liver cells.
Oxidative stress is a systemic manifestation which is associated with 
increased production of oxidizing species or a significant decrease 
in the effectiveness of antioxidant defenses such as glutathione [21]. 
Production of reactive oxygen species such as free radicals and peroxides 
is a particularly destructive aspect of oxidative stress. Oxidative stress 
is thought to be involved in the development of atherosclerosis [22] and 
heart failure [23]. Antioxidant inhibits the oxidation of these reactive 
Table 2: Effect of Bauhinia variegata (L.) was extracted with 








I 5.37±0.26c 5.14±0.07c 5.68±0.27b
II 3.81±0.24 3.56±0.16 7.23±0.33
III 4.92±0.30a 4.73±0.23b 6.10±0.29a
IV 5.64±0.23c 5.06±0.32c 5.57±0.24c
V 5.71±0.19c 5.34±0.24c 4.93±0.23c
The data are expressed as mean±SEM.; n=6 in each group. Control 
group (I); HCD group (II); HCD+BVME 100 mg/kg body weight (III); 
HCD+BVME 200 mg/kg body weight (IV); and HCD+atorvastatin 40 mg/kg 
body weight (V). Statistical significance testing for the comparisons was made 
by ANOVA, followed by post hoc test. ap<0.05, bp<0.01, cp<0.001, and nsp>0.05 
compared with HCD group. HCD: High cholesterol diet, BVME: Bauhinia 
variegata (L.) was extracted with methanol, SEM: Standard error of mean, 
SOD: Superoxide dismutase, GSH: Glutathione reduced, LPO: Lipid peroxidation
Table 4: Effect of Bauhinia variegata (L.) was extracted with 
methanol on liver toxicity in hyperlipidemic rats
Groups AST (U/l) ALT (U/l) Alkaline/acid 
phosphatase (U/l)
I 84.13±2.47c 28.11±0.83c 147.82±2.47b
II 103.90±3.18 37.98±1.91 165.35±2.05
III 91.41±2.01a 32.95±0.99a 153.51±1.57a
IV 87.92±2.88b 31.29±0.68b 151.08±2.30b
V 79.94±3.3c 23.68±0.94c 130.33±4.61c
The data are expressed as mean±SEM; n=6 in each group. Control 
group (I); HCD group (II); HCD+BVME 100 mg/kg body weight (III); HCD+BVME 
200 mg/kg body weight (IV); and HCD+atorvastatin 40 mg/kg body 
weight (V). Statistical significance testing for the comparisons was made by 
ANOVA, followed by post hoc test. ap<0.05, bp<0.01, cp<0.001, and nsp>0.05 
compared with HCD group. HCD: High cholesterol diet, BVME: Bauhinia 
variegata (L.) was extracted with methanol, SEM: Standard error of mean, 
AST: Aspartate transaminase, ALT: Alanine transferase
Table 5: Effect of Bauhinia variegata (L.) was extracted with 
methanol on atherogenic index in hyperlipidemic rats













Percentage protection _ _ 33.67% 43.54% 64.63%
The data are expressed as mean±SEM; n=6 in each group. Control 
group (I); HCD group (II); HCD+BVME 100 mg/kg b.wt (III); HCD+BVME 
200 mg/kg b.wt (IV); and HCD+atorvastatin 40 mg/kg b.wt (V). Statistical 
significance testing for the comparisons was made by ANOVA, followed 
by post hoc test. ap<0.05, bp<0.01, cp<0.001, and nsp>0.05 compared with HCD 
group. HCD: High cholesterol diet, BVME: Bauhinia variegata (L.) was extracted 
with methanol, SEM: Standard error of mean
Fig. 2: Histopathological study of liver. (a) Control rat (×400), showing histoarchitecture of central vein and normal hepatocytes 
surrounding it. (b) Rat fed with high-fat diet (×400), showing significant damage with fatty infiltration and tissue degeneration. (c) Rat 
fed with high-fed diet and treated with B. variegata (100 mg/kg b. wt) (×400), showing mild reduction of fatty change with normal 
hepatocytes. (d) Rat fed with high-fed diet and treated with B. variegata (200 mg/kg b. wt) (×400), showing significant reduction of 
fatty infiltration with restoration of normal liver histological appearance. (e) Rat fed with high-fat diet and treated with atorvastatin 
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oxygen species. As B. variegata (L.) is a potent antioxidant [5,6]; hence, 
the study was also assessed for its antioxidant activity. The oxidative 
stress parameters such as SOD, GSH, and LPO were performed. This 
study suggests that the dose levels higher of BVME possess antioxidative 
activity and the flavonoids present in the extract may be responsible for 
increasing the levels of SOD and GSH by scavenging the reactive oxygen 
species. The LPO was assessed by TBARS method. The pathogenesis of 
several diseases is caused due to free radical-induced LPO or oxidative 
stress [24,25]. Hypercholesterolemia induces not only atherosclerosis 
but also produces a lot of free radicals in blood and tissues [24,26]. The 
combined effect of decreased LPO and increase in antioxidant enzyme 
activities in the hepatic tissue, cardiac, and aorta would definitely lower 
the oxidative stress. Similar observations were obtained by Sharma H 
et al., 2018 [27].
Hyperlipidemia is one of the reasons for the cause of hepatopathy. The 
queer sign of hepatic damage is leakage of important cellular enzymes 
such as AST, ALT, and ALP into the serum [28]. Hence, in the present 
study, these cellular enzymes were as the biomarkers for the hepatic 
damage. There was a significant change in the levels of AST and ALT. 
This shows liver toxicity in Groups 2 and 3 and no toxicity in treated 
groups.
CONCLUSIONS
With this current study and findings, it can be concluded that 
methanolic stem bark extract of B. variegata (L.) contains quercetin, a 
flavonoid that is potent hypolipidemic agent and an antioxidant. It was 
helpful in decreasing the levels of total cholesterol, TGs, LDL, and VLDL 
whereas increasing the levels of HDL. It also had a beneficial effect 
on antioxidative activity by increasing the levels of SOD and GSH and 
reducing the levels of LPO. Furthermore, there was not any liver toxicity 
in the treatment of hyperlipidemia with BVME.
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